267 related articles for article (PubMed ID: 20498310)
41. Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives.
Okado JB; Avaca-Crusca JS; Oliveira AL; Dabul ANG; Camargo ILBDC
J Glob Antimicrob Resist; 2018 Sep; 14():209-216. PubMed ID: 29753135
[TBL] [Abstract][Full Text] [Related]
42. In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.
Dortet L; Anguel N; Fortineau N; Richard C; Nordmann P
Int J Infect Dis; 2013 Nov; 17(11):e1076-7. PubMed ID: 23578850
[TBL] [Abstract][Full Text] [Related]
43. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.
Julian K; Kosowska-Shick K; Whitener C; Roos M; Labischinski H; Rubio A; Parent L; Ednie L; Koeth L; Bogdanovich T; Appelbaum PC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3445-8. PubMed ID: 17620372
[TBL] [Abstract][Full Text] [Related]
44. Dysregulation of mprF and dltABCD expression among daptomycin-non-susceptible MRSA clinical isolates.
Bayer AS; Mishra NN; Cheung AL; Rubio A; Yang SJ
J Antimicrob Chemother; 2016 Aug; 71(8):2100-4. PubMed ID: 27121398
[TBL] [Abstract][Full Text] [Related]
45. Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains.
Yang SJ; Xiong YQ; Dunman PM; Schrenzel J; François P; Peschel A; Bayer AS
Antimicrob Agents Chemother; 2009 Jun; 53(6):2636-7. PubMed ID: 19289517
[TBL] [Abstract][Full Text] [Related]
46. Whole-genome sequencing identifies MprF mutations in a genetically diverse population of daptomycin non-susceptible Staphylococcus aureus in Australia.
Lim C; Coombs GW; Daley DA; Shoby P; Mowlaboccus S
Int J Antimicrob Agents; 2024 May; 63(5):107144. PubMed ID: 38494147
[TBL] [Abstract][Full Text] [Related]
47. In vivo development of heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA), GISA and daptomycin resistance in a patient with meticillin-resistant S. aureus endocarditis.
Kirby A; Mohandas K; Broughton C; Neal TJ; Smith GW; Pai P; Nistal de Paz C
J Med Microbiol; 2009 Mar; 58(Pt 3):376-380. PubMed ID: 19208891
[TBL] [Abstract][Full Text] [Related]
48. Investigating a possible link between antiseptic treatment and the increased occurrence of daptomycin-resistant Staphylococcus aureus.
Wendel AF; Otchwemah R; Layer-Nicolaou F; Mattner F; Tellez-Castillo CJ; Skov R; Oberländer H; Werner G; Strommenger B
Clin Microbiol Infect; 2023 Oct; 29(10):1334.e1-1334.e6. PubMed ID: 37321393
[TBL] [Abstract][Full Text] [Related]
49. β-Lactam-Induced Cell Envelope Adaptations, Not Solely Enhanced Daptomycin Binding, Underlie Daptomycin-β-Lactam Synergy in Methicillin-Resistant Staphylococcus aureus.
Lew C; Mishra NN; Bayer AS; Rose WE
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0035621. PubMed ID: 34097478
[TBL] [Abstract][Full Text] [Related]
50. Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia.
Chen CJ; Huang YC; Chiu CH
J Antimicrob Chemother; 2015 Nov; 70(11):2965-72. PubMed ID: 26216581
[TBL] [Abstract][Full Text] [Related]
51. Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
Nigo M; Diaz L; Carvajal LP; Tran TT; Rios R; Panesso D; Garavito JD; Miller WR; Wanger A; Weinstock G; Munita JM; Arias CA; Chambers HF
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28232309
[TBL] [Abstract][Full Text] [Related]
52. Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall.
Bayer AS; Schneider T; Sahl HG
Ann N Y Acad Sci; 2013 Jan; 1277(1):139-58. PubMed ID: 23215859
[TBL] [Abstract][Full Text] [Related]
53. Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding.
Jones T; Yeaman MR; Sakoulas G; Yang SJ; Proctor RA; Sahl HG; Schrenzel J; Xiong YQ; Bayer AS
Antimicrob Agents Chemother; 2008 Jan; 52(1):269-78. PubMed ID: 17954690
[TBL] [Abstract][Full Text] [Related]
54. Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.
Singh KV; Arias CA; Murray BE
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122892
[TBL] [Abstract][Full Text] [Related]
55. Rapid resistance development to three antistaphylococcal therapies in antibiotic-tolerant staphylococcus aureus bacteremia.
Miller CR; Monk JM; Szubin R; Berti AD
PLoS One; 2021; 16(10):e0258592. PubMed ID: 34669727
[TBL] [Abstract][Full Text] [Related]
56. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
Camargo IL; Neoh HM; Cui L; Hiramatsu K
Antimicrob Agents Chemother; 2008 Dec; 52(12):4289-99. PubMed ID: 18824611
[TBL] [Abstract][Full Text] [Related]
57. New Mechanistic Insights into Purine Biosynthesis with Second Messenger c-di-AMP in Relation to Biofilm-Related Persistent Methicillin-Resistant Staphylococcus aureus Infections.
Li L; Li Y; Zhu F; Cheung AL; Wang G; Bai G; Proctor RA; Yeaman MR; Bayer AS; Xiong YQ
mBio; 2021 Dec; 12(6):e0208121. PubMed ID: 34724823
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
Patel D; Husain M; Vidaillac C; Steed ME; Rybak MJ; Seo SM; Kaatz GW
Int J Antimicrob Agents; 2011 Nov; 38(5):442-6. PubMed ID: 21840181
[TBL] [Abstract][Full Text] [Related]
59. Impact of Exposure of Methicillin-Resistant Staphylococcus aureus to Polyhexanide
Renzoni A; Von Dach E; Landelle C; Diene SM; Manzano C; Gonzales R; Abdelhady W; Randall CP; Bonetti EJ; Baud D; O'Neill AJ; Bayer A; Cherkaoui A; Schrenzel J; Harbarth S; François P
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784678
[TBL] [Abstract][Full Text] [Related]
60. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
Rehm SJ; Boucher H; Levine D; Campion M; Eisenstein BI; Vigliani GA; Corey GR; Abrutyn E
J Antimicrob Chemother; 2008 Dec; 62(6):1413-21. PubMed ID: 18782781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
